Keegan to Lead Strategic Growth and Drive AI-Enabled Innovation in Digital Cognitive Health Solutions ...

Outcomes may improve with disease-modifying drugs and lifestyle change if Alzheimer's could be identified earlier.

Tuesday, Sage Therapeutics, Inc. (NASDAQ:SAGE) released topline results from the Phase 2 LIGHTWAVE study to evaluate the ...

Researchers have illustrated that synthetic cannabis can reduce agitation in Alzheimer's patients by an average of 30%.

BrainCheck, Inc., a digital health innovator delivering next-generation technology into the growing digital cognitive assessment market, announced a new study published in Frontiers in Psychology ...

Researchers show that a pill form of the drug dronabinol, an FDA-approved synthetic version of marijuana's main ingredient, THC, reduces agitation in patients with Alzheimer's by an average of 30%.

Zety®, a career service dedicated to helping people improve their resumes and cover letters, today announced the findings from its HR and AI Recruitment Report, which polled 500 HR managers about ...

Changes are coming to Aces after they fall short of three-peat Nobel Prize awarded to ‘godfather of AI’ who warned that ...

Kodak’s artificial intelligence tool, “Memory Shots,” enables people with dementia to visually reconstruct their memories ...

Dementia is a devastating disease that impacts one in 10 older Americans. But while many people want to avoid developing ...

A groundbreaking study has uncovered a chilling connection between falls and the risk of dementia in older adults ...

If you’re having memory problems and are above 60, get tested for free to check if your cognitive health is really impaired.